REQUEST A DEMO
Total
USD $0.00
Search more companies

J.Molner AS (Estonia)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: J.Molner AS Profile Updated: July 09, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

J. Molner is a pharmaceutical company providing its customers with the highest level of generic drugs for specialty generic pharmaceuticals with a focus on the USA and Canadian markets. Provides service clients with analytical chemistry services and cost-saving commercial stability solutions. J. Molner’s activities are based on its high-tech laboratory capable of performing a wide range of chemical analyses and studies that may be required for drug development and verifying the quality and content of various pharmaceuticals.

Headquarters
Akadeemia tee 21/5
Tallinn; Harju county; Postal Code: 12618

Contact Details: Purchase the J.Molner AS report to view the information.

Website: https://www.jmolner.com/

Basic Information
Total Employees:
Purchase the J.Molner AS report to view the information.
Outstanding Shares:
Purchase the J.Molner AS report to view the information.
Registered Capital:
Purchase the J.Molner AS report to view the information.
Financial Auditors:
Purchase the J.Molner AS report to view the information.
Incorporation Date:
2022
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Finance Officer
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
94.9%
Subsidiaries
The J. Molner Company Inc
100%
The J. Molner Company Llc
100%
Company Performance
Financial values in the chart are available after J.Molner AS report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
381.55%
Total operating revenue
375.36%
Operating profit (EBIT)
-97.94%
EBITDA
-91.8%
Net Profit (Loss) for the Period
-120.67%
Total assets
84.1%
Total equity
-6.93%
Operating Profit Margin (ROS)
84.32%
Net Profit Margin
88.96%
Return on Equity (ROE)
-67.13%
Debt to Equity Ratio
184.94%
Quick Ratio
-0.77%
Cash Ratio
-0.77%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?